Clinical Trial Update: The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of a once-daily dose of atomoxetine on ADHD-related insomnia in children and adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Insomnia

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Attention Deficit Hyperactivity Disorder, Insomnia | Phase 4 | Status: COMPLETED